Bionime Corporation (TPE:4737)
65.10
+0.20 (0.31%)
At close: Mar 27, 2026
Bionime Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 423.12 | 321.23 | 391.82 | 214.49 | 253.09 |
Short-Term Investments | - | 61.16 | 57.19 | 63.19 | 59.63 |
Cash & Short-Term Investments | 423.12 | 382.39 | 449.01 | 277.68 | 312.71 |
Cash Growth | 10.65% | -14.84% | 61.70% | -11.20% | -21.65% |
Accounts Receivable | 533.64 | 670.75 | 520.39 | 692.82 | 373.69 |
Other Receivables | 6.9 | 58.58 | 22.29 | 14.35 | 13.42 |
Receivables | 540.54 | 729.33 | 542.68 | 707.16 | 387.11 |
Inventory | 456.41 | 571.14 | 491.26 | 538.43 | 590.16 |
Prepaid Expenses | 64.39 | 73.45 | 122.06 | 102.73 | - |
Other Current Assets | 76.66 | 17.88 | 12.23 | 10.62 | 99.74 |
Total Current Assets | 1,561 | 1,774 | 1,617 | 1,637 | 1,390 |
Property, Plant & Equipment | 2,537 | 2,596 | 2,492 | 2,482 | 2,542 |
Long-Term Investments | 187.9 | 166.15 | 55.82 | 36.1 | 36.1 |
Other Intangible Assets | 919.39 | 643.59 | 643.67 | 13.81 | 14.41 |
Long-Term Deferred Tax Assets | 229.93 | 157.65 | 95.38 | 56.36 | 50.54 |
Long-Term Deferred Charges | - | 132.49 | - | 493.04 | 327.71 |
Other Long-Term Assets | 268.84 | 310.8 | 396.94 | 265.17 | 203.22 |
Total Assets | 5,704 | 5,781 | 5,301 | 4,983 | 4,564 |
Accounts Payable | 142.9 | 191.41 | 148.61 | 180.12 | 151.99 |
Accrued Expenses | - | 491.97 | 312.92 | 389.6 | - |
Short-Term Debt | 473.66 | 967.44 | 504.74 | 352.03 | 507.78 |
Current Portion of Long-Term Debt | - | 609.83 | 604.3 | 422.73 | 361.08 |
Current Portion of Leases | 2.89 | 9.93 | 9.89 | 3.86 | 4.86 |
Current Income Taxes Payable | 123.26 | 4.9 | 5.43 | 6.4 | 7.56 |
Current Unearned Revenue | - | 1.88 | 1.92 | 10.71 | 2.29 |
Other Current Liabilities | 1,336 | 33.64 | 21.19 | 45.51 | 293.88 |
Total Current Liabilities | 2,078 | 2,311 | 1,609 | 1,411 | 1,329 |
Long-Term Debt | 1,863 | 1,578 | 1,687 | 1,485 | 1,156 |
Long-Term Leases | 3.35 | 0.99 | 10.35 | 5.66 | 0.72 |
Long-Term Deferred Tax Liabilities | 0.94 | 1.45 | 0.47 | 0.28 | 0.49 |
Other Long-Term Liabilities | 2.76 | 0.63 | 0.56 | 0.63 | 0.95 |
Total Liabilities | 3,949 | 3,892 | 3,307 | 2,903 | 2,488 |
Common Stock | 672.73 | 610.39 | 608.2 | 606.87 | 622.89 |
Additional Paid-In Capital | 1,079 | 1,116 | 1,209 | 1,303 | 1,362 |
Retained Earnings | -167.22 | 13.06 | 146.07 | 163.03 | 225.52 |
Treasury Stock | - | - | - | - | -138.14 |
Comprehensive Income & Other | 160.59 | 140.94 | 22.94 | -0.11 | -3.14 |
Total Common Equity | 1,745 | 1,880 | 1,986 | 2,072 | 2,069 |
Minority Interest | 10.21 | 9.04 | 7.17 | 8.11 | 6.73 |
Shareholders' Equity | 1,756 | 1,889 | 1,993 | 2,081 | 2,076 |
Total Liabilities & Equity | 5,704 | 5,781 | 5,301 | 4,983 | 4,564 |
Total Debt | 2,343 | 3,166 | 2,816 | 2,269 | 2,031 |
Net Cash (Debt) | -1,920 | -2,784 | -2,367 | -1,992 | -1,718 |
Net Cash Per Share | -28.55 | -41.52 | -35.14 | -29.48 | -25.68 |
Filing Date Shares Outstanding | 67.53 | 67.13 | 66.89 | 66.75 | 66.31 |
Total Common Shares Outstanding | 67.53 | 67.13 | 66.89 | 66.75 | 66.31 |
Working Capital | -517.19 | -536.8 | 8.24 | 225.66 | 60.29 |
Book Value Per Share | 25.85 | 28.00 | 29.69 | 31.05 | 31.21 |
Tangible Book Value | 826.02 | 1,236 | 1,342 | 2,059 | 2,055 |
Tangible Book Value Per Share | 12.23 | 18.42 | 20.07 | 30.84 | 30.99 |
Land | - | 1,421 | 1,421 | 1,421 | 1,421 |
Buildings | - | 1,077 | 902.59 | 883.6 | 881.21 |
Machinery | - | 1,727 | 1,652 | 1,536 | 1,500 |
Leasehold Improvements | - | 20.21 | 19.47 | 19.29 | 18.31 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.